Itb-Med logo
VerifiedBiotechnology Research· Founded 2016

Itb-Med

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches.

7-day free trial · no credit card

HeadquartersUnited StatesEmployees40(11 to 50)Annual revenue<$1MFounded year2016Websiteitb-med.comLinkedIn profileLinkedIn

Verified contacts

43

available on Kipplo

LinkedIn employees

40

11 to 50 range

Open roles

no listings

Distinct roles

33

indexed titles

Tech stack

2

tools in use

Monthly traffic

71

organic / mo

Sign up free to see all 43 verified contacts at Itb-Med

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

43 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Itb-Med

33 distinct titles indexed · top 10 shown.

  • 7itb-med
  • 2clinical research associate
  • 2research scientist
  • 1()
  • 1associate clinical trial manager
  • 1chief financial officer
  • 1chief legal and compliance officer
  • 1clinical trial associate
  • 1clinical trial manager
  • 1cmc project coordinator
  • +23more titles

Sign up to unlock all 43 contacts at Itb-Med

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 43 verified contacts at Itb-Med

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Itb-Med | Kipplo Discover